ESAB Q1 2026 sales hit record $746 million, up 10%; core organic sales fell 1%
ESAB reported first quarter 2026 results with record sales of $746 million, up 10% on a reported basis but down 1% on a core organic basis. GAAP earnings per diluted share fell to $0.82 from $1.14, while core adjusted earnings per diluted share rose 5% to $1.31, and the company reiterated its full-year 2026 outlook.
Key points
- Net sales of $746 million, up 10% reported and down 1% core organic; the company cited the EWM and Aktiv acquisitions as outperforming with double-digit growth
- GAAP diluted EPS from continuing operations was $0.82 versus $1.14 a year earlier; core adjusted diluted EPS was $1.31 versus $1.25
- Core adjusted EBITDA of $136 million rose 6%, while core adjusted EBITDA margin fell 80 basis points to 19.0%, reflecting EWM dilution and Iran conflict costs
- Full-year 2026 outlook reiterated: core adjusted EBITDA of $575 million to $595 million and core adjusted EPS of $5.70 to $5.90; Eddyfi acquisition expected to close mid-year and is not included
The filing
Written by AI on Nov 8, 2026, 1:05 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 07, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.